Have a personal or library account? Click to login
Care of patients with non-small-cell lung cancer stage III – the Central European real-world experience Cover

Care of patients with non-small-cell lung cancer stage III – the Central European real-world experience

Radiology and Oncology
Volume 54 (2020): Issue 2 (June 2020)
By: Milada Zemanova,  Robert Pirker,  Lubos Petruzelka,  Zuzana Zbozínkova,  Dragana Jovanovic,  Mirjana Rajer,  Krisztina Bogos,  Gunta Purkalne,  Vesna Ceriman,  Subhash Chaudhary,  Igor Richter,  Jirí Kufa,  Lenka Jakubikova,  Marius Zemaitis,  Marketa Cernovska,  Leona Koubkova,  Zdenka Vilasova,  Karin Dieckmann,  Attila Farkas,  Jelena Spasic,  Katerina Fröhlich,  Andreas Tiefenbacher,  Virag Hollosi,  Juraj Kultan,  Iveta Kolarová and  Jiri Votruba  
Open Access
|May 2020

References

  1. Nappi A, Gallicchio R, Simeon V, Nardelli A, Pelagalli A, Zupa A, et al. [F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients. Radiol Oncol 2015; 49: 320-6. doi: 10.1515/raon-2015-0043
    Open DOISearch in Google ScholarBack to article
  2. Eberhardt WE, De Ruysscher D, Weder W, Le Péchoux C, De Leyn P, Hoffmann H, et al. Panel members. 2nd ESMO consensus conference in lung cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol 2015; 26: 1573-88. doi: 10.1093/annonc/mdv187
    Open DOISearch in Google ScholarBack to article
  3. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2: 706-14. doi: 10.1097/JTO.0b013e31812f3c1a
    Open DOISearch in Google ScholarBack to article
  4. Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Boards, and Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016; 11: 39-51. doi: 10.1016/j.jtho.2015.09.009.
    Open DOISearch in Google ScholarBack to article
  5. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE collaborative group. J Clin Oncol 2008; 26: 3552-9. doi: 10.1200/ JCO.2007.13.9030
    Open DOISearch in Google ScholarBack to article
  6. NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet 2014; 383: 1561-71. doi: 10.1016/S0140-6736(13)62159-5
    Open DOISearch in Google ScholarBack to article
  7. Betticher DC, Hsu Schmitz SF, Totsch M, Hansen E, Joss C, von Briel C, et al. Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study. Br J Cancer 2006; 94: 1099-106.
    Search in Google ScholarBack to article
  8. Sher DJ, Fidler MJ, Liptay MJ, Koshy M. Comparative effectiveness of neo-adjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer. Lung Cancer 2015; 88: 267-74. doi: 10.1016/j.lungcan.2015.03.015
    Open DOISearch in Google ScholarBack to article
  9. Thomas M, Rube C, Hoffknecht P, Macha HN, Freitag L, Linder A, et al. Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer. Lancet Oncol 2008; 9: 636-48. doi: 10.1016/S1470-2045(08)70156-6
    Open DOISearch in Google ScholarBack to article
  10. Garrido P, Gonzalez-Larriba JL, Insa A, Provencio M, Torres A, Isla D, et al. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non-small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. J Clin Oncol 2007; 25: 4736-42.
    Search in Google ScholarBack to article
  11. Barlési F, Doddoli C, Torre JP, Giudicelli R, Fuentes P, Thomas P, et al. Comparative prognostic features of stage IIIAN2 and IIIB non-small-cell lung cancer patients treated with surgery after induction therapy. Eur J Cardiothorac Surg 2005; 28: 629-34. doi: 10.1016/j.ejcts.2005.06.018
    Open DOISearch in Google ScholarBack to article
  12. Auperin A, Le Pechoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010 28: 2181-90. doi: 10.1200/JCO.2009.26.2543
    Open DOISearch in Google ScholarBack to article
  13. Ma L, Men Y, Feng L, Kang J, Sun X, Yuan M, et al. A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer. Radiol Oncol 2019; 53: 6-14. doi: 10.2478/raon-2019-0006
    Open DOISearch in Google ScholarBack to article
  14. Antonia SJ, Villegas A, Daniel D, Vicente D, Murakami S, Hui R, et al. PACIFIC Investigators. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N Engl J Med 2017; 377: 1919-29. doi: 10.1056/ NEJMoa1709937
    Open DOISearch in Google ScholarBack to article
  15. Zhang Z, Sun J. Interval censoring. Stat Methods Med Res 2010; 19: 53-70. doi: 10.1177/0962280209105023
    Open DOISearch in Google ScholarBack to article
  16. Senan S, Brade A, Wang LH, Vansteenkiste J, Dakhil S, Biesma B, et al. PROCLAIM: Randomized phase III trial of pemetrexed-cisplatin or etoposide-cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small-cell lung cancer. J Clin Oncol 2016; 34: 953-62. doi: 10.1200/JCO.2015.64.8824
    Open DOISearch in Google ScholarBack to article
  17. Ramlau R, Cufer T, Berzinec P, Dziadziuszko R, Olszewski W, Popper H, et al. INSIGHT study team. Epidermal growth factor receptor mutation-positive non-small-cell lung cancer in the real-world setting in Central Europe: The INSIGHT Study. 10: 1370-4. J Thorac Oncol 2015; 10: 1370-4. doi: 10.1097/ JTO.0000000000000621
    Open DOISearch in Google ScholarBack to article
  18. Barlesi F, Mazieres J, Merlio JP, Debieuvre D, Mosser J, Lena H, et al. Biomarkers France contributors. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet 2016; 387: 1415-26. doi: 10.1016/S0140-6736(16)00004-0
    Open DOISearch in Google ScholarBack to article
  19. Hofman P. ALK in Non-Small Cell Lung Cancer (NSCLC): pathobiology, epidemiology, detection from tumor tissue and algorithm diagnosis in a daily practice. Cancers 2017; 9: pii: E107. doi: 10.3390/cancers9080107
    Open DOISearch in Google ScholarBack to article
  20. Ryan KJ, Skinner KE, Fernandes AW, Punekar RS, Pavilack M, Walker MS, et al. Real-world outcomes in patients with unresected stage III non-small cell lung cancer. Med Oncol 2019; 36: 24. doi: 10.1007/s12032-019-1249-1
    Open DOISearch in Google ScholarBack to article
  21. Ryan KJ, Skinner KE, Fernandes AW, Punekar RS, Pavilack M, Walker MS, et al. Real-world treatment patterns among patients with unresected stage III non-small-cell lung cancer. Future Oncol 2019; 15: 2943-53. doi: 10.2217/ fon-2018-0939
    Open DOISearch in Google ScholarBack to article
  22. Moore S, Leung B, Wu J, Ho C. Real-world treatment of stage III NSCLC: the role of trimodality treatment in the era of immunotherapy. J Thorac Oncol 2019; 14: 1430-9. doi: 10.1016/j.jtho.2019.04.005
    Open DOISearch in Google ScholarBack to article
  23. Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, et al. The impact of extent and location of mediastinal lymph node involvement on survival in stage III non-small cell lung cancer patients treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys 2012; 83: 340-7. doi: 10.1016/j.ijrobp.2011.05.070
    Open DOISearch in Google ScholarBack to article
  24. Van der Meer FS, Schramel FM, Van Vulpen M, El Sharouni SY. Feasibility of concomitant chemoradiotherapy in daily practice for patients with NSCLC stage III. Anticancer Res 2016; 36: 4673-6. doi: 10.21873/anticanres.11019
    Open DOISearch in Google ScholarBack to article
  25. Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet 2009; 374: 379-86. doi: 10.1016/S0140-6736(09)60737-6
    Open DOISearch in Google ScholarBack to article
DOI: https://doi.org/10.2478/raon-2020-0026 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 209 - 220
Submitted on: Jan 9, 2020
|
Accepted on: Apr 14, 2020
|
Published on: May 28, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
diagnostic procedures,
multimodality treatment,
non-small-cell lung cancer,
stage III
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2020 Milada Zemanova, Robert Pirker, Lubos Petruzelka, Zuzana Zbozínkova, Dragana Jovanovic, Mirjana Rajer, Krisztina Bogos, Gunta Purkalne, Vesna Ceriman, Subhash Chaudhary, Igor Richter, Jirí Kufa, Lenka Jakubikova, Marius Zemaitis, Marketa Cernovska, Leona Koubkova, Zdenka Vilasova, Karin Dieckmann, Attila Farkas, Jelena Spasic, Katerina Fröhlich, Andreas Tiefenbacher, Virag Hollosi, Juraj Kultan, Iveta Kolarová, Jiri Votruba, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 54 (2020): Issue 2 (June 2020)Next article